PYGO2 and breast carcinoma: In addition, Pygo2 can facilitates histone methyltransferase (HMT) and histone acetyltransferase (HAT) interaction with β-catenin and further augment Wnt1-induced, TCF/LEF-dependent transcriptional activation in breast cancer cells [34].